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ABSTRACT
This case report describes an unusual form of gout, called miliarial gout, in association with carpal tunnel syndrome in a 54-year-old woman. 
Miliarial gout was first described in 2007 and is a very rare presentation of chronic tophaceous gout. The latter condition can cause carpal 
tunnel syndrome, but this association has not previously been described in association with miliarial gout. In addition, the authors discuss 
the use of the parsimony principle in internal medicine whereby a single cause is first sought for different symptoms presenting at the same 
time.
LEARNING POINTS
• Miliarial gout, a form of chronic tophaceous gout, is a very rare clinical presentation of the disease.
• Patients with miliarial gout, despite subcutaneous nodules, may present with other organ involvement.
• Carpal tunnel syndrome in patients with gout may be caused by monosodium urate crystal deposition.
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INTRODUCTION
Monosodium urate crystals (MSU) are deposited in gout[1], a disease which has a prevalence of 0.9–2.5% depending on the country[2]. Chronic 
tophaceous gout is a particular form of the disease that manifests as MSU deposition intradermally or within the subcutaneous tissues of the 
skin[3]. A new form of this condition, called miliarial gout, was described in 2007 and consists of multiple tiny intradermal papules containing 
a white to cream-coloured material and scattered on an erythematous base[4]. Several case reports have since described this particular form 
of gout, but to our knowledge, no association between miliarial gout and carpal tunnel syndrome has been previously reported.
CASE DESCRIPTION
A 54-year-old woman was referred for a rheumatology consultation by her family physician because of paraesthesia of the fingers of the right 
hand, which worsened at night and after physical activity. The symptoms had started 3 years previously and had a remitting/relapsing course, 
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with significant aggravation during the preceding 3 months. A neurologist examined the patient and an EMG and echography confirmed the 
diagnosis of carpal tunnel syndrome. However, the condition worsened despite treatment with oral non-steroidal anti-inflammatory drugs. 
The anamnesis included menopause at the age of 49 years, no tobacco or alcohol consumption, no similar family history, and hypertension 
treated with beta-blockers, diuretics and aspirin.
The physical examination showed a patient in no distress, with normal vital signs (BP 123/80 mm/Hg, pulse 68/minute), a BMI of 29.6 kg/
m2, no tender or swollen joints, and hyposensitivity of the first, second and third fingers of the right hand. Examination of the skin identified 
white non-tender maculopapular lesions on an erythematous base, with a diameter of 2–5 mm2 (Fig. 1).
Figure 1. Miliarial gout manifested as white maculopapular lesions on an erythematous base, with a diameter of 2–5 mm2
Figure 2. Morphological analysis of the content of a maculopapular skin lesion revealed 
groups of transparent anuclear structures, identified as monosodium urate acid crystals
Figure 3. Morphological analysis of the right carpal tunnel aspirate revealed groups of 
transparent anuclear structures, identified as monosodium urate acid crystals
Laboratory investigations confirmed a mild inflammatory syndrome with an erythrocyte sedimentation rate of 17 mm/h (normal range 2–15 
mm/h), an increased C-reactive protein level of 12 mg/dl (normal range <6 mg/dl) and a mild decrease in the glomerular filtration rate (52 
ml/min/1.73m2). The patient’s serum uric acid level was 6.1 mg/dl. Morphological examination of material from the skin papules and carpal 
tunnel aspirate revealed MSU crystals, confirming the diagnosis (Figs. 2 and 3).
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DISCUSSION
As chronic tophaceous gout can cause carpal tunnel syndrome[5], miliarial gout, being a form of chronic tophaceous gout, could possibly 
result in the same condition, although no such cases have been previously described.
We diagnosed miliarial gout, an extremely rare form of chronic tophaceous gout, that had caused carpal tunnel syndrome in a patient with 
multiple risk factors for gout including overweight, a mildly decreased glomerular filtration rate, and aspirin and diuretic intake.
The patient was managed according to the EULAR evidence-based recommendations for gout[2], which included lifestyle changes with diet 
modification and febuxostat therapy for hypouricaemia. The patient has stopped taking diuretics. A local corticosteroid injection was also 
administered, which resulted in significant regression of clinical symptoms. After 3 months of follow-up, the patient’s uric acid level had 
dropped to 4.7 mg/dl and the symptoms had resolved. 
CONCLUSION
The parsimony principle, also called Occam’s razor, can be applied in the clinical setting when two clinical entities are present together. This 
principle was first described in 1347 and states that "Entities are not to be multiplied without necessity" (Non sunt multiplicanda entia sine 
necessitate). Applying the principle in medicine means a single cause is first sought even for multiple symptoms/syndromes. Application of 
the parsimony principle in our case resulted in the diagnosis of miliarial gout with carpal tunnel syndrome. 
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